Cuba studies safety of Abdala COVID-19 vaccine in children from six to 11 months
Abdala, designed and manufactured at the CIGB, has since October 2021 been authorized for emergency use by the Cuban regulatory ...
Abdala, designed and manufactured at the CIGB, has since October 2021 been authorized for emergency use by the Cuban regulatory ...
The Cuban vaccine shipment is part of the 7 million bulbs manufactured on the island for the voluntary immunization campaign ...
According to a statement from the Center for Genetic Engineering and Biotechnology (CIGB), it is a study without placebo, which ...
Of the 48,000 volunteers involved in the phase III clinical trial, only 153 were infected with the virus and among ...
The news was announced this Monday in Havana by the Center for Genetic Engineering and Biotechnology (CIGB).
However, Cuban specialists aspire to higher figures, as confirmed by the Director of Clinical Research at the Center for Genetic ...
+The measure provides for the inoculation with Cuban drugs, and in a “gradual manner,” of medical students, health and pharmaceutical ...
The study applied in three-shot doses included more than 48,000 volunteers from the capitals of Santiago de Cuba, Guantánamo and ...
Until this weekend, 101,943 volunteers had received the initial dose of the Soberana 02 and Abdala candidates, or a placebo, ...
In a televised address, Venezuelan President Nicolás Maduro announced that 60,000 units will arrive in the country to be applied ...
The phase III trial for Abdala, from the Center for Genetic Engineering and Biotechnology (CIGB), will take place in the ...
In addition to Guantánamo, the effectiveness study covers the provincial capital of Santiago de Cuba.
OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.